Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials

KZ Vardakas, GL Voulgaris, A Maliaros… - The Lancet infectious …, 2018 - thelancet.com
Background The findings of randomised controlled trials (RCT), observational studies, and
meta-analyses vary regarding the effectiveness of prolonged β-lactam infusion. We aimed to …

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - Clinical infectious …, 2013 - academic.oup.com
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …

A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis

JM Dulhunty, JA Roberts, JS Davis… - American journal of …, 2015 - atsjournals.org
Rationale: Continuous infusion of β-lactam antibiotics may improve outcomes because of
time-dependent antibacterial activity compared with intermittent dosing. Objectives: To …

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

FS Taccone, PF Laterre, T Dugernier, H Spapen… - Critical care, 2010 - Springer
Introduction Altered pharmacokinetics (PK) in critically ill patients can result in insufficient
serum β-lactam concentrations when standard dosages are administered. Previous studies …

Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy

L Seyler, F Cotton, FS Taccone, D De Backer… - Critical Care, 2011 - Springer
Introduction Sepsis is responsible for important alterations in the pharmacokinetics of
antibiotics. Continuous renal replacement therapy (CRRT), which is commonly used in …

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis

JA Roberts, J Lipman - Clinical pharmacokinetics, 2006 - Springer
Abstract Treatment of sepsis remains a significant challenge with persisting high mortality
and morbidity. Early and appropriate antibacterial therapy remains an important intervention …

A systematic review on clinical benefits of continuous administration of β-lactam antibiotics

JA Roberts, S Webb, D Paterson, KM Ho… - Critical care …, 2009 - journals.lww.com
Objective: The clinical benefits of extended infusion or continuous infusion of β-lactam
antibiotics remain controversial. We systematically reviewed the literature to determine …

Breaking down the breakpoints: rationale for the 2022 Clinical and Laboratory Standards Institute revised piperacillin-tazobactam breakpoints against …

PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
Piperacillin-tazobactam (PTZ) is one of the most common antibiotics administered to
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

JA Roberts, CMJ Kirkpatrick, MS Roberts… - International journal of …, 2010 - Elsevier
The objectives of this study were (i) to compare the plasma concentration–time profiles for
first-dose and steady-state piperacillin administered by intermittent or continuous dosing to …

Piperacillin penetration into tissue of critically ill patients with sepsis—bolus versus continuous administration?

JA Roberts, MS Roberts, TA Robertson… - Critical care …, 2009 - journals.lww.com
Objective: To describe a pharmacokinetic model of piperacillin concentrations in plasma and
subcutaneous tissue when administered by bolus dosing and continuous infusion in …